z-logo
open-access-imgOpen Access
Nucleotide Pyrophosphatase/Phosphodiesterase 1 Is Responsible for Degradation of Antisense Phosphorothioate Oligonucleotides
Author(s) -
Marzena Wójcik,
Marcin Cieślak,
Wojciech J. Stec,
James W. Goding,
Maria Koziołkiewicz
Publication year - 2007
Publication title -
oligonucleotides/oligonucleotides.
Language(s) - English
Resource type - Journals
eISSN - 1557-8526
pISSN - 1545-4576
DOI - 10.1089/oli.2007.0021
Subject(s) - exonuclease , oligonucleotide , phosphodiester bond , pyrophosphatase , biology , biochemistry , inorganic pyrophosphatase , nucleotide , phosphodiesterase , microbiology and biotechnology , nuclease , enzyme , pyrophosphatases , dna , rna , gene , pyrophosphate , dna polymerase
The rapid degradation of unmodified phosphodiester oligodeoxynucleotides (PO-oligos) by exo -and endonucleases limits their application as antisense constructs and requires the synthesis and use of modified oligonucleotides. Phosphorothioate analogs of oligonucleotides (PS-oligos) are much more stable against nucleolytic degradation than their unmodified counterparts, and this is one of the reasons for which they are a promising class of antisense oligonucleotides. However, PS-oligos also undergo slow hydrolysis by enzymes present in plasma. The oligonucleotide degradation proceeds mainly from the 3' -end, resulting in the formation of a typical ladder of shorter products and the release of the mononucleoside 5' -phosphorothioates. So far, little has been known concerning the molecular identity of the enzymes involved in the degradation of PS-oligos. We now identify the human plasma 3' -exonuclease responsible for their degradation as a soluble form of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) (EC 3.1.4.1/EC 3.6.1.9), also known as the plasma cell differentiation antigen PC-1. We also show that adenosine or deoxyadenosine (alpha-thio)triphosphates can act as potent inhibitors of NPPs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here